ISA Pharmaceuticals’ Chief Scientific Officer Prof. Dr. Cornelis Melief Receives AACR-CRI Lloyd J. Old Award in Cancer Immunology

Tuesday, March 19, 2019

Recognition for outstanding and innovative cancer research

ISA Pharmaceuticals B.V., a clinical-stage immuno-oncology company, announced that its Chief Scientific Officer Prof. Dr. Cornelis Melief will receive the AACR-CRI Lloyd J. Old Award in Cancer Immunology 2019 from the American Association of Cancer Research (AACR) and the Cancer Research Institute.

The AACR-CRI Lloyd J. Old Award in Cancer Immunology recognizes an active scientist whose outstanding and innovative research has had a major impact on the cancer field and has the potential to stimulate new directions in cancer immunology.

The award was established in honor of the late Lloyd J. Old, MD, who is considered the “Founding Father of Modern Tumor Immunology.” Dr. Old’s outstanding research in the field of cancer immunology as well as his leadership in fostering the field has had a far-reaching impact on cancer research and treatment.

Prof. Melief will deliver his award lecture titled “Adventures in Cancer Immunotherapy” at the AACR Annual Meeting 2019 in Atlanta, GA, USA, on April 2, 2019. Read more

Whom to contact at Leiden Bio Science Park?

Contacts